Liraglutide
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Novo Nordisk · Phase 3 · Completed · Enrollment 846
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Lira 3.0 mg | Obesity or overweight | 3.0 mg | 56 | n/r | 2.3% at week 56 |
| Lira 1.8 mg | Obesity or overweight | 1.8 mg | 56 | n/r | 2% at week 56 |
| Placebo | Obesity or overweight | n/r | 56 | n/r | -0.1% at week 56 |